Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
![A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers](http://www.bioadvisers.com/wp-content/uploads/2018/06/%E5%A8%9C.jpg)
A new research revealed that the CRISPR–Cas9 genome editing technique may increase cancer risk - Biotech Advisers
![Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-019-0089-y/MediaObjects/41392_2019_89_Fig1_HTML.png)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects | Signal Transduction and Targeted Therapy
![CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019 CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019](https://m.dw.com/image/47168666_101.jpg)
CRISPR-Cas9 babies likely to die earlier, Berkeley study says | Science| In-depth reporting on science and technology | DW | 03.06.2019
![Nature Medicine on Twitter: Nature Medicine on Twitter:](https://pbs.twimg.com/media/Dz3TNFLXgAQnA0e.png)
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
![Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d0e0cdce-5dc7-44ad-a51e-e8a41311ce2e/gr3_lrg.jpg)
Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research: Molecular Therapy - Methods & Clinical Development
![CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41698-019-0080-7/MediaObjects/41698_2019_80_Fig1_HTML.png)
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
![Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine](https://thumbs-prod.si-cdn.com/hKkkoysHLGMvgdKA8OhbnWLbN1s=/fit-in/1600x0/https://public-media.si-cdn.com/filer/bc/78/bc780a37-4f25-40c7-ac3b-09de377ab51c/istock-952017558.jpg)
Four U.S. CRISPR Trials Editing Human DNA to Research New Treatments | Science | Smithsonian Magazine
![Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch](http://retractionwatch.com/wp-content/uploads/2018/03/nature-methods.gif)
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
![Nature Medicine on Twitter: Nature Medicine on Twitter:](https://pbs.twimg.com/media/Dfqie-0XcAAUv58.jpg)
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
![Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. - Nat. Med. - X-MOL](https://xpic.x-mol.com/20190220%2F10.1038_s41591-019-0343-4.jpg)